Minimal Important Difference ID'd in Voice Handicap Index-10

Share this content:
Minimal Important Difference ID'd in Voice Handicap Index-10
Minimal Important Difference ID'd in Voice Handicap Index-10

THURSDAY, Sept. 28, 2017 (HealthDay News) -- A difference of 6 on the Voice Handicap Index-10 (VHI-10) total score may represent a minimal important difference (MID) for patients with voice disorders, according to a study published online Sept. 28 in JAMA Otolaryngology -- Head & Neck Surgery.

Stephanie Misono, M.D., M.P.H., from the University of Minnesota in Minneapolis, and colleagues used an anchor-based approach to estimate MID in the VHI-10 total score in a cohort study. A volunteer sample of adult patients visiting a voice clinic, with a variety of voice disorders, completed the VHI-10 in conjunction with a global rating of change at baseline and two weeks later. An MID was identified using an anchor-based approach.

The researchers found that the mean change in VHI-10 score was 1 for patients reporting no change on the global change score; the mean change was also 1 for those reporting a small change. The mean change in VHI-10 was 6 for those reporting a moderate change in voice symptoms, while those reporting a large change had a mean change in score of 9. There was a correlation of 0.32 between the global change score and change in VHI-10 score.

"Given the lack of differentiation between small and no change and the modest correlation between the global change score and change in the VHI-10 score, additional studies are needed," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »